Home > Result Summaries: Compounds > Hepatitis A (Inactivated), Hepatitis B (Recombinant) Vaccine > Result Summary for 208127/125

Result Summary for 208127/125

Result Summary

Protocol ID:	208127/125
Clinical Study ID:	208127/125 (Ext-HAB-038 Month 90)
Official Title:	A double-blind, randomized study to evaluate the immunogenicity and reactogenicity of two different lots of GlaxoSmithKline Biologicals' combined hepatitis A / hepatitis B vaccine in healthy children between 6 and 15 years of age.
Phase:	Phase 3
Study Indications or Diseases:	Viral Hepatitis Vaccines
Generic Name:	Hepatitis A (Inactivated), Hepatitis B (Recombinant) Vaccine
Trade/Product Name:	Twinrix;Twinrix
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Diaz-Mitoma et al. (2008) Long-term antibody persistence induced by a combined hepatitis A and B vaccine in children and adolescents. Vaccine. 26(14):1759-1763.